Use of Warfarin After the First Trimester in Pregnant Women With APS
Status:
Recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
Evaluation of shifting to oral vitamin K antagonist after the first trimester instead of
using low molecular weight heparin (LMWH) throughout pregnancy in pregnant women with
antiphospholipid syndrome (APS)